发明名称 TREATMENT OF AUTOIMMUNE DISEASE BY ANTI-CCL20 ANTIBODY
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a pharmaceutical which inhibits the CCL20 function expressed in the autoimmune disease site and is effective for the autoimmune disease. <P>SOLUTION: The autoimmune disease treating agent comprises a monoclonal antibody responsive to CCL20 or its fragment as an active ingredient. <P>COPYRIGHT: (C)2009,JPO&INPIT</p>
申请公布号 JP2009096716(A) 申请公布日期 2009.05.07
申请号 JP20060011525 申请日期 2006.01.19
申请人 EISAI R & D MANAGEMENT CO LTD 发明人 MURAMOTO KENZO;HORIZOE TATSUO;IMAI TOSHIO;NISHIMURA MIYUKI;MIZUNO KEIKO
分类号 A61K39/395;A61P19/02;A61P19/10;A61P29/00;A61P37/06;C12N5/10;C12N15/09;C12Q1/02;G01N33/15;G01N33/50 主分类号 A61K39/395
代理机构 代理人
主权项
地址